Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | YL211 |
Trade Name | |
Synonyms | YL-211|YL 211 |
Drug Descriptions |
YL211 is an antibody-drug conjugate (ADC) comprising an antibody targeting MET linked to a topoisomerase 1 inhibitor, which potentially induces cell cycle arrest and apoptosis and inhibits tumor growth (Cancer Res (2024) 84 (6_Supplement): 2615). |
DrugClasses | MET Antibody 29 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
YL211 | YL211 | 0 | 1 |